Cargando…
Estimation of magnesium in patients with functional hypoparathyroidism
CONTEXT: It is evident that about 30-50% of patients with Vitamin D deficiency (VDD) do not manifest develop secondary hyperparathyroidism (SHPT). A number of theories have been proposed to explain this lack of SHPT, including hypomagnesemia. SETTINGS AND DESIGN: Retrospective review of laboratory d...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192988/ https://www.ncbi.nlm.nih.gov/pubmed/25364677 http://dx.doi.org/10.4103/2230-8210.141365 |
_version_ | 1782338886064668672 |
---|---|
author | Kannan, Subramanian Mahadevan, Shriraam Velayutham, P. Bharath, R. Kumaravel, V. Muthukumaran, J. Premkumar, A. |
author_facet | Kannan, Subramanian Mahadevan, Shriraam Velayutham, P. Bharath, R. Kumaravel, V. Muthukumaran, J. Premkumar, A. |
author_sort | Kannan, Subramanian |
collection | PubMed |
description | CONTEXT: It is evident that about 30-50% of patients with Vitamin D deficiency (VDD) do not manifest develop secondary hyperparathyroidism (SHPT). A number of theories have been proposed to explain this lack of SHPT, including hypomagnesemia. SETTINGS AND DESIGN: Retrospective review of laboratory database. MATERIALS AND METHODS: We evaluated the differences in serum magnesium (Mg) levels among those with VDD with or without SHPT. A retrospective review of 6255 laboratory data of bone mineral profiles performed in the period of 2007–2013. After excluding patients with hypercalcemia, renal dysfunction/unknown kidney function and primary hypothyroidism, the remaining 1323 patient data were analyzed. SHPT was defined as serum parathyroid hormone >65 in those with VDD. STATISTICAL ANALYSIS USED: ANOVA and Wilcoxon tests as appropriate to compare means. Multivariate logistic regression to analyze relation between variables and outcome of SHPT. RESULTS: We noted that 55% patients (n = 727) had VDD, and among those who had VDD, 23% (n = 170) were hypocalcemic (corrected serum calcium <8.5). Patients with VDD who did not exhibit SHPT were 56% (n = 407). The mean (±standard deviation) serum Mg levels in the entire cohort (n = 1323) was 1.94 ± 0.26 mg/dl and 1.95 ± 0.26 mg/dl in VDD cohort and 2 ± 0.31 mg/dl in the VDD-hypocalcemic cohort. There was no statistical difference in the Mg levels among those with SHPT compared to those without SHPT (P = 0.14). Serum calcium and phosphorus were lower in those with SHPT (P = 0.06 and P < 0.001, respectively). In multivariate logistic regression, serum calcium (P = 0.043), phosphorus (P < 0.001) and severe VDD (P < 0.001) independently correlated with occurrence of SHPT in VDD. CONCLUSIONS: Serum Mg levels did not explain the functional hypoparathyroidism seen in about half of the patients with VDD. A low normal serum calcium and phosphorus levels are more likely to be associated with VDD patients who develop SHPT. |
format | Online Article Text |
id | pubmed-4192988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-41929882014-11-01 Estimation of magnesium in patients with functional hypoparathyroidism Kannan, Subramanian Mahadevan, Shriraam Velayutham, P. Bharath, R. Kumaravel, V. Muthukumaran, J. Premkumar, A. Indian J Endocrinol Metab Original Article CONTEXT: It is evident that about 30-50% of patients with Vitamin D deficiency (VDD) do not manifest develop secondary hyperparathyroidism (SHPT). A number of theories have been proposed to explain this lack of SHPT, including hypomagnesemia. SETTINGS AND DESIGN: Retrospective review of laboratory database. MATERIALS AND METHODS: We evaluated the differences in serum magnesium (Mg) levels among those with VDD with or without SHPT. A retrospective review of 6255 laboratory data of bone mineral profiles performed in the period of 2007–2013. After excluding patients with hypercalcemia, renal dysfunction/unknown kidney function and primary hypothyroidism, the remaining 1323 patient data were analyzed. SHPT was defined as serum parathyroid hormone >65 in those with VDD. STATISTICAL ANALYSIS USED: ANOVA and Wilcoxon tests as appropriate to compare means. Multivariate logistic regression to analyze relation between variables and outcome of SHPT. RESULTS: We noted that 55% patients (n = 727) had VDD, and among those who had VDD, 23% (n = 170) were hypocalcemic (corrected serum calcium <8.5). Patients with VDD who did not exhibit SHPT were 56% (n = 407). The mean (±standard deviation) serum Mg levels in the entire cohort (n = 1323) was 1.94 ± 0.26 mg/dl and 1.95 ± 0.26 mg/dl in VDD cohort and 2 ± 0.31 mg/dl in the VDD-hypocalcemic cohort. There was no statistical difference in the Mg levels among those with SHPT compared to those without SHPT (P = 0.14). Serum calcium and phosphorus were lower in those with SHPT (P = 0.06 and P < 0.001, respectively). In multivariate logistic regression, serum calcium (P = 0.043), phosphorus (P < 0.001) and severe VDD (P < 0.001) independently correlated with occurrence of SHPT in VDD. CONCLUSIONS: Serum Mg levels did not explain the functional hypoparathyroidism seen in about half of the patients with VDD. A low normal serum calcium and phosphorus levels are more likely to be associated with VDD patients who develop SHPT. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4192988/ /pubmed/25364677 http://dx.doi.org/10.4103/2230-8210.141365 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kannan, Subramanian Mahadevan, Shriraam Velayutham, P. Bharath, R. Kumaravel, V. Muthukumaran, J. Premkumar, A. Estimation of magnesium in patients with functional hypoparathyroidism |
title | Estimation of magnesium in patients with functional hypoparathyroidism |
title_full | Estimation of magnesium in patients with functional hypoparathyroidism |
title_fullStr | Estimation of magnesium in patients with functional hypoparathyroidism |
title_full_unstemmed | Estimation of magnesium in patients with functional hypoparathyroidism |
title_short | Estimation of magnesium in patients with functional hypoparathyroidism |
title_sort | estimation of magnesium in patients with functional hypoparathyroidism |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192988/ https://www.ncbi.nlm.nih.gov/pubmed/25364677 http://dx.doi.org/10.4103/2230-8210.141365 |
work_keys_str_mv | AT kannansubramanian estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism AT mahadevanshriraam estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism AT velayuthamp estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism AT bharathr estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism AT kumaravelv estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism AT muthukumaranj estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism AT premkumara estimationofmagnesiuminpatientswithfunctionalhypoparathyroidism |